Diabetes
News from the FDA/CDC
FDA approves new ready-to-inject glucagon product
Dasiglucagon is the third of newer-generation glucagon products that don’t require multistep reconstitution in emergency hypoglycemic situations...
From the Journals
Use of complimentary and alternative medicine common in diabetes patients
Roughly half of diabetes patients may be using complementary and alternative medicine, but most don’t tell their healthcare providers.
Conference Coverage
STEP 4: Ongoing semaglutide treatment extends weight loss
After weekly semaglutide injections produced an 11% average weight loss, continued use led to continued loss, while discontinuation meant regain...
Feature
Comic books help explain type 1 diabetes to all ages
Overcoming the challenges in managing type 1 diabetes can sometimes feel like an unappreciated superpower.
From the Journals
Women with PCOS at increased risk for COVID-19
Women with PCOS may fear an increased infection risk "will further compromise timely access to health care and serve to increase the sense of...
From the Journals
Diabetes prevention moves toward reality as studies published
Newly published 3-year data on teplizumab in high-risk individuals and combination therapy with liraglutide in new-onset type 1 diabetes show...
Feature
High obesity rates in Southern states magnify COVID threats
At least 29 states have green-lighted obesity for inclusion in the first phases of the COVID-19 vaccine rollout. That could overwhelm government...
From the Journals
Type 2 diabetes linked to increased risk for Parkinson’s
Both observational and genetic data have provided “convincing evidence” that T2D predisposes people to an increased risk for Parkinson’s disease...
Guidelines
‘Major update’ of BP guidance for kidney disease; treat to 120 mm Hg
“[Chapter one] of the guidelines is devoted to blood pressure measurement ... if [targeting] 120 [mm Hg systolic], the emphasis is on 120 measured...
From the Journals
Two popular screening tests for gestational diabetes clinically equivalent
“The unknown question was whether diagnosing and treating more women would be associated with any differences in any of the multiple GDM-...
From the Journals
Semaglutide for meaningful weight loss in obesity and diabetes?
“This is by far the best result we had with any weight loss medicine in patients with diabetes,” says the senior author of the STEP 2 clinical...